Skip to main content
×
Home
    • Aa
    • Aa

Imipenem Resistance Among Pseudomonas aeruginosa Isolates Risk Factors for Infection and Impact of Resistance on Clinical and Economic Outcomes

  • Ebbing Lautenbach (a1) (a2) (a3), Mark G. Weiner (a4), Irving Nachamkin (a5), Warren B. Bilker (a2) (a3), Angela Sheridan (a5) and Neil O. Fishman (a1)...
Abstract
Objectives.

To identify risk factors for infection with imipenem-resistant Pseudomonas aeruginosa and determine the impact of imipenem resistance on clinical and economic outcomes among patients infected with P. aeruginosa.

Designs.

An ecologic study, a case-control study, and a retrospective cohort study.

Setting.

A 625-bed tertiary care medical center.

Patients.

All patients who had an inpatient clinical culture positive for P. aeruginosa between January 1, 1999, and December 31, 2000.

Results.

From 1991 through 2000, the annual prevalence of imipenem resistance among P. aeruginosa isolates increased significantly (P<.001 by the χ2 test for trend). Among 879 patients infected with P. aeruginosa during 1999-2000, a total of 142 had imipenem-resistant P. aeruginosa infection (the case group), whereas 737 had imipenem-susceptible P. aeruginosa infection (the control group). The only independent risk factor for imipenem-resistant P. aeruginosa infection was prior fluoroquinolone use (adjusted odds ratio, 2.52 [95% confidence interval {CI}, 1.61-3.92]; P<.001). Compared with patients infected with imipenem-susceptible P. aeruginosa, patients infected with imipenem-resistant P. aeruginosa had longer subsequent hospitalization durations (15.5 days vs 9 days; P = .02) and greater hospital costs ($81,330 vs $48,381; P<.001). The mortality rate among patients infected with imipenem-resistant P. aeruginosa was 31.1%, compared with 16.7% for patients infected with imipenem-susceptible P. aeruginosa (relative risk, 1.86 [95% CI, 1.38-2.51]; P<.001). In multivariable analyses, there remained an independent association between infection with imipenem-resistant P. aeruginosa and mortality.

Conclusions.

The prevalence of imipenem resistance among P. aeruginosa strains has increased markedly in recent years and has had a significant impact on both clinical and economic outcomes. Our results suggest that curtailing use of other antibiotics (particularly fluoroquinolones) may be important in attempts to curb further emergence of imipenem resistance.

Copyright
Corresponding author
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 825 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104–6021, (elautenb@cceb.med.upenn.edu)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

, , , , , . . ; :–.1. AC Fluit RN Jones FJ Schmitz J Acar R Gupta J Verhoef Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998 Clin Infect Dis 2000 30 454460

3. M Hilf , VL Yu , JA Sharp , JJ Zuravleff , JA Korvick , RR Muder . Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlation in a prospective study of 200 patients. Am J Med 1989; 87:540546.

, , , . . ; :–.4. F Vidal J Mensa M Almela et alEpidemiology and outcome of bacteremia, with special emphasis on the influence of antibiotic treatmentPseudomonas aeruginosa Arch Intern Med 1996 156 21212126

, , . . ; :–.5. A King K Shannon I Phillips Resistance to imipenem in Pseudomonas aeruginosa J Antimicrob Chemother 1995 36 10371041

. . ; ():–.6. LJV Piddock Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994 Drugs 1995 49 Suppl 22935

, , , , , . . ; :–.8. H Pai JW Kim J Kim J Lee K Choe N Gotoh Carbapenem resistance mechanisms in clinical isolatesPseudomonas aeruginosa Antimicrob Agents Chemother 2001 45 480484

, , , . . ; :–.9. AD Harris TB Karchmer Y Carmeli MH Samore Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review Clin Infect Dis 2001 32 10551061

, , , , , . . ; :–.10. R Gross AS Morgan DE Kinky M Weiner GQ Gibson NO Fishman Impact of a hospital-based antimicrobial management program on clinical and economic outcomes Clin Infect Dis 2001 33 289295

, , . . ; :–.11. RA Deyo DC Cherkin MA Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 1992 45 613619

13. P Armitage . Test for linear trend in proportions and frequencies. Biometrics 1955; 11:375386.

, , . . ; :–.17. GW Sun TL Shook GL Kay Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis J Clin Epidemiol 1996 49 907916

, , , , . . ; :–.19. B Cao H Wang H Sun Y Zhu M Chen Risk factors and clinical outcomes of nosocomial multidrug resistant infectionsPseudomonas aeruginosa J Hosp Infect 2004 57 112118

, , , , . . ; :–.20. AD Harris D Smith JA Johnson DD Bradham MC Roghmann Risk factors for imipenem-resistant among hospitalized patientsPseudomonas aeruginosa Clin Infect Dis 2002 34 340345

, , . . ; :–.21. N Troillet MH Samore Y Carmeli Imipenem-resistant : risk factors and antibiotic susceptibility patternsPseudomonas aeruginosa Clin Infect Dis 1997 25 10941098

, , , . . ; : –.22. H Fukuda M Hosaka K Hirai S Iyobe New norfloxacin resistance gene in PAOPseudomonas aeruginosa Antimicrob Agents Chemother 1990 34 17571761

, , . . ; :–.23. G Aubert B Pozzetto G Dorche Emergence of quinolone-imipenem cross-resistance in after fluoroquinolone therapyPseudomonas aeruginosa J Antimicrob Chemother 1992 29 307312

25. DM Livermore . Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34:634640.

, , , . . ; :–.28. Y Carmeli N Troillet AW Karchmer M Samore Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa Arch Intern Med 1999 159 11271132

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 4 *
Loading metrics...

Abstract views

Total abstract views: 102 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st July 2017. This data will be updated every 24 hours.